Substituted AZA- and diazacycloheptane and -cyclooctane
申请人:BASF Aktiengesellschaft
公开号:US06352981B1
公开(公告)日:2002-03-05
Aza- and diazacyclohexane and -cyclooctane compounds of the following formula:
Ar1—A—B—Ar2 (I)
where Ar1, A, B and Ar2 have the meanings stated in the description have a high affinity for the dopamine D3 receptor and can therefore be used to treat disorders which respond to dopamine D3 ligands.